Global Biosimilar Market Growth (Status and Outlook) 2022-2028
- LP 4914473
- 101 Pages
- March 2022
- Pharmaceuticals
The United States Biosimilar market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Biosimilar market, reaching US$ million by the year 2028. As for the Europe Biosimilar landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 6-year period.
Global main Biosimilar players cover Qilu Pharmaceutical, Bio-Thera, Zhejiang Hisun, and Shanghai Henlius, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Biosimilar market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Biosimilar Monoclonal Antibodies
Biosimilar Insulin
Others
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Cancer
Immunological Diseases
Diabetes
Others
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Qilu Pharmaceutical
Bio-Thera
Zhejiang Hisun
Shanghai Henlius
Innovent Biologics
Jiangsu Hengrui
Gan&Lee
Tonghua Dongbao
United Laboratory
3SBIO
Luye Pharma
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Biosimilar Market Size 2017-2028
2.1.2 Biosimilar Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Biosimilar Segment by Type
2.2.1 Biosimilar Monoclonal Antibodies
2.2.2 Biosimilar Insulin
2.2.3 Others
2.3 Biosimilar Market Size by Type
2.3.1 Biosimilar Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Biosimilar Market Size Market Share by Type (2017-2022)
2.4 Biosimilar Segment by Application
2.4.1 Cancer
2.4.2 Immunological Diseases
2.4.3 Diabetes
2.4.4 Others
2.5 Biosimilar Market Size by Application
2.5.1 Biosimilar Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Biosimilar Market Size Market Share by Application (2017-2022)
3 Biosimilar Market Size by Player
3.1 Biosimilar Market Size Market Share by Players
3.1.1 Global Biosimilar Revenue by Players (2020-2022)
3.1.2 Global Biosimilar Revenue Market Share by Players (2020-2022)
3.2 Global Biosimilar Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Biosimilar by Regions
4.1 Biosimilar Market Size by Regions (2017-2022)
4.2 Americas Biosimilar Market Size Growth (2017-2022)
4.3 APAC Biosimilar Market Size Growth (2017-2022)
4.4 Europe Biosimilar Market Size Growth (2017-2022)
4.5 Middle East & Africa Biosimilar Market Size Growth (2017-2022)
5 Americas
5.1 Americas Biosimilar Market Size by Country (2017-2022)
5.2 Americas Biosimilar Market Size by Type (2017-2022)
5.3 Americas Biosimilar Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Biosimilar Market Size by Region (2017-2022)
6.2 APAC Biosimilar Market Size by Type (2017-2022)
6.3 APAC Biosimilar Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Biosimilar by Country (2017-2022)
7.2 Europe Biosimilar Market Size by Type (2017-2022)
7.3 Europe Biosimilar Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Biosimilar by Region (2017-2022)
8.2 Middle East & Africa Biosimilar Market Size by Type (2017-2022)
8.3 Middle East & Africa Biosimilar Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Biosimilar Market Forecast
10.1 Global Biosimilar Forecast by Regions (2023-2028)
10.1.1 Global Biosimilar Forecast by Regions (2023-2028)
10.1.2 Americas Biosimilar Forecast
10.1.3 APAC Biosimilar Forecast
10.1.4 Europe Biosimilar Forecast
10.1.5 Middle East & Africa Biosimilar Forecast
10.2 Americas Biosimilar Forecast by Country (2023-2028)
10.2.1 United States Biosimilar Market Forecast
10.2.2 Canada Biosimilar Market Forecast
10.2.3 Mexico Biosimilar Market Forecast
10.2.4 Brazil Biosimilar Market Forecast
10.3 APAC Biosimilar Forecast by Region (2023-2028)
10.3.1 China Biosimilar Market Forecast
10.3.2 Japan Biosimilar Market Forecast
10.3.3 Korea Biosimilar Market Forecast
10.3.4 Southeast Asia Biosimilar Market Forecast
10.3.5 India Biosimilar Market Forecast
10.3.6 Australia Biosimilar Market Forecast
10.4 Europe Biosimilar Forecast by Country (2023-2028)
10.4.1 Germany Biosimilar Market Forecast
10.4.2 France Biosimilar Market Forecast
10.4.3 UK Biosimilar Market Forecast
10.4.4 Italy Biosimilar Market Forecast
10.4.5 Russia Biosimilar Market Forecast
10.5 Middle East & Africa Biosimilar Forecast by Region (2023-2028)
10.5.1 Egypt Biosimilar Market Forecast
10.5.2 South Africa Biosimilar Market Forecast
10.5.3 Israel Biosimilar Market Forecast
10.5.4 Turkey Biosimilar Market Forecast
10.5.5 GCC Countries Biosimilar Market Forecast
10.6 Global Biosimilar Forecast by Type (2023-2028)
10.7 Global Biosimilar Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Qilu Pharmaceutical
11.1.1 Qilu Pharmaceutical Company Information
11.1.2 Qilu Pharmaceutical Biosimilar Product Offered
11.1.3 Qilu Pharmaceutical Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Qilu Pharmaceutical Main Business Overview
11.1.5 Qilu Pharmaceutical Latest Developments
11.2 Bio-Thera
11.2.1 Bio-Thera Company Information
11.2.2 Bio-Thera Biosimilar Product Offered
11.2.3 Bio-Thera Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Bio-Thera Main Business Overview
11.2.5 Bio-Thera Latest Developments
11.3 Zhejiang Hisun
11.3.1 Zhejiang Hisun Company Information
11.3.2 Zhejiang Hisun Biosimilar Product Offered
11.3.3 Zhejiang Hisun Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Zhejiang Hisun Main Business Overview
11.3.5 Zhejiang Hisun Latest Developments
11.4 Shanghai Henlius
11.4.1 Shanghai Henlius Company Information
11.4.2 Shanghai Henlius Biosimilar Product Offered
11.4.3 Shanghai Henlius Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Shanghai Henlius Main Business Overview
11.4.5 Shanghai Henlius Latest Developments
11.5 Innovent Biologics
11.5.1 Innovent Biologics Company Information
11.5.2 Innovent Biologics Biosimilar Product Offered
11.5.3 Innovent Biologics Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Innovent Biologics Main Business Overview
11.5.5 Innovent Biologics Latest Developments
11.6 Jiangsu Hengrui
11.6.1 Jiangsu Hengrui Company Information
11.6.2 Jiangsu Hengrui Biosimilar Product Offered
11.6.3 Jiangsu Hengrui Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Jiangsu Hengrui Main Business Overview
11.6.5 Jiangsu Hengrui Latest Developments
11.7 Gan&Lee
11.7.1 Gan&Lee Company Information
11.7.2 Gan&Lee Biosimilar Product Offered
11.7.3 Gan&Lee Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Gan&Lee Main Business Overview
11.7.5 Gan&Lee Latest Developments
11.8 Tonghua Dongbao
11.8.1 Tonghua Dongbao Company Information
11.8.2 Tonghua Dongbao Biosimilar Product Offered
11.8.3 Tonghua Dongbao Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Tonghua Dongbao Main Business Overview
11.8.5 Tonghua Dongbao Latest Developments
11.9 United Laboratory
11.9.1 United Laboratory Company Information
11.9.2 United Laboratory Biosimilar Product Offered
11.9.3 United Laboratory Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 United Laboratory Main Business Overview
11.9.5 United Laboratory Latest Developments
11.10 3SBIO
11.10.1 3SBIO Company Information
11.10.2 3SBIO Biosimilar Product Offered
11.10.3 3SBIO Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 3SBIO Main Business Overview
11.10.5 3SBIO Latest Developments
11.11 Luye Pharma
11.11.1 Luye Pharma Company Information
11.11.2 Luye Pharma Biosimilar Product Offered
11.11.3 Luye Pharma Biosimilar Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 Luye Pharma Main Business Overview
11.11.5 Luye Pharma Latest Developments
12 Research Findings and Conclusion
Table 1. Biosimilar Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Biosimilar Monoclonal Antibodies
Table 3. Major Players of Biosimilar Insulin
Table 4. Major Players of Others
Table 5. Biosimilar Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 6. Global Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 7. Global Biosimilar Market Size Market Share by Type (2017-2022)
Table 8. Biosimilar Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 9. Global Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 10. Global Biosimilar Market Size Market Share by Application (2017-2022)
Table 11. Global Biosimilar Revenue by Players (2020-2022) & ($ Millions)
Table 12. Global Biosimilar Revenue Market Share by Player (2020-2022)
Table 13. Biosimilar Key Players Head office and Products Offered
Table 14. Biosimilar Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Biosimilar Market Size by Regions 2017-2022 & ($ Millions)
Table 18. Global Biosimilar Market Size Market Share by Regions (2017-2022)
Table 19. Americas Biosimilar Market Size by Country (2017-2022) & ($ Millions)
Table 20. Americas Biosimilar Market Size Market Share by Country (2017-2022)
Table 21. Americas Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 22. Americas Biosimilar Market Size Market Share by Type (2017-2022)
Table 23. Americas Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 24. Americas Biosimilar Market Size Market Share by Application (2017-2022)
Table 25. APAC Biosimilar Market Size by Region (2017-2022) & ($ Millions)
Table 26. APAC Biosimilar Market Size Market Share by Region (2017-2022)
Table 27. APAC Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 28. APAC Biosimilar Market Size Market Share by Type (2017-2022)
Table 29. APAC Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 30. APAC Biosimilar Market Size Market Share by Application (2017-2022)
Table 31. Europe Biosimilar Market Size by Country (2017-2022) & ($ Millions)
Table 32. Europe Biosimilar Market Size Market Share by Country (2017-2022)
Table 33. Europe Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 34. Europe Biosimilar Market Size Market Share by Type (2017-2022)
Table 35. Europe Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 36. Europe Biosimilar Market Size Market Share by Application (2017-2022)
Table 37. Middle East & Africa Biosimilar Market Size by Region (2017-2022) & ($ Millions)
Table 38. Middle East & Africa Biosimilar Market Size Market Share by Region (2017-2022)
Table 39. Middle East & Africa Biosimilar Market Size by Type (2017-2022) & ($ Millions)
Table 40. Middle East & Africa Biosimilar Market Size Market Share by Type (2017-2022)
Table 41. Middle East & Africa Biosimilar Market Size by Application (2017-2022) & ($ Millions)
Table 42. Middle East & Africa Biosimilar Market Size Market Share by Application (2017-2022)
Table 43. Key Market Drivers & Growth Opportunities of Biosimilar
Table 44. Key Market Challenges & Risks of Biosimilar
Table 45. Key Industry Trends of Biosimilar
Table 46. Global Biosimilar Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 47. Global Biosimilar Market Size Market Share Forecast by Regions (2023-2028)
Table 48. Global Biosimilar Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 49. Global Biosimilar Market Size Market Share Forecast by Type (2023-2028)
Table 50. Global Biosimilar Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 51. Global Biosimilar Market Size Market Share Forecast by Application (2023-2028)
Table 52. Qilu Pharmaceutical Details, Company Type, Biosimilar Area Served and Its Competitors
Table 53. Qilu Pharmaceutical Biosimilar Product Offered
Table 54. Qilu Pharmaceutical Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 55. Qilu Pharmaceutical Main Business
Table 56. Qilu Pharmaceutical Latest Developments
Table 57. Bio-Thera Details, Company Type, Biosimilar Area Served and Its Competitors
Table 58. Bio-Thera Biosimilar Product Offered
Table 59. Bio-Thera Main Business
Table 60. Bio-Thera Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 61. Bio-Thera Latest Developments
Table 62. Zhejiang Hisun Details, Company Type, Biosimilar Area Served and Its Competitors
Table 63. Zhejiang Hisun Biosimilar Product Offered
Table 64. Zhejiang Hisun Main Business
Table 65. Zhejiang Hisun Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 66. Zhejiang Hisun Latest Developments
Table 67. Shanghai Henlius Details, Company Type, Biosimilar Area Served and Its Competitors
Table 68. Shanghai Henlius Biosimilar Product Offered
Table 69. Shanghai Henlius Main Business
Table 70. Shanghai Henlius Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 71. Shanghai Henlius Latest Developments
Table 72. Innovent Biologics Details, Company Type, Biosimilar Area Served and Its Competitors
Table 73. Innovent Biologics Biosimilar Product Offered
Table 74. Innovent Biologics Main Business
Table 75. Innovent Biologics Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 76. Innovent Biologics Latest Developments
Table 77. Jiangsu Hengrui Details, Company Type, Biosimilar Area Served and Its Competitors
Table 78. Jiangsu Hengrui Biosimilar Product Offered
Table 79. Jiangsu Hengrui Main Business
Table 80. Jiangsu Hengrui Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 81. Jiangsu Hengrui Latest Developments
Table 82. Gan&Lee Details, Company Type, Biosimilar Area Served and Its Competitors
Table 83. Gan&Lee Biosimilar Product Offered
Table 84. Gan&Lee Main Business
Table 85. Gan&Lee Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 86. Gan&Lee Latest Developments
Table 87. Tonghua Dongbao Details, Company Type, Biosimilar Area Served and Its Competitors
Table 88. Tonghua Dongbao Biosimilar Product Offered
Table 89. Tonghua Dongbao Main Business
Table 90. Tonghua Dongbao Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 91. Tonghua Dongbao Latest Developments
Table 92. United Laboratory Details, Company Type, Biosimilar Area Served and Its Competitors
Table 93. United Laboratory Biosimilar Product Offered
Table 94. United Laboratory Main Business
Table 95. United Laboratory Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 96. United Laboratory Latest Developments
Table 97. 3SBIO Details, Company Type, Biosimilar Area Served and Its Competitors
Table 98. 3SBIO Biosimilar Product Offered
Table 99. 3SBIO Main Business
Table 100. 3SBIO Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 101. 3SBIO Latest Developments
Table 102. Luye Pharma Details, Company Type, Biosimilar Area Served and Its Competitors
Table 103. Luye Pharma Biosimilar Product Offered
Table 104. Luye Pharma Biosimilar Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 105. Luye Pharma Main Business
Table 106. Luye Pharma Latest Developments
List of Figures
Figure 1. Biosimilar Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Biosimilar Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Biosimilar Market Size Market Share by Type in 2021
Figure 7. Biosimilar in Cancer
Figure 8. Global Biosimilar Market: Cancer (2017-2022) & ($ Millions)
Figure 9. Biosimilar in Immunological Diseases
Figure 10. Global Biosimilar Market: Immunological Diseases (2017-2022) & ($ Millions)
Figure 11. Biosimilar in Diabetes
Figure 12. Global Biosimilar Market: Diabetes (2017-2022) & ($ Millions)
Figure 13. Biosimilar in Others
Figure 14. Global Biosimilar Market: Others (2017-2022) & ($ Millions)
Figure 15. Global Biosimilar Market Size Market Share by Application in 2021
Figure 16. Global Biosimilar Revenue Market Share by Player in 2021
Figure 17. Global Biosimilar Market Size Market Share by Regions (2017-2022)
Figure 18. Americas Biosimilar Market Size 2017-2022 ($ Millions)
Figure 19. APAC Biosimilar Market Size 2017-2022 ($ Millions)
Figure 20. Europe Biosimilar Market Size 2017-2022 ($ Millions)
Figure 21. Middle East & Africa Biosimilar Market Size 2017-2022 ($ Millions)
Figure 22. Americas Biosimilar Value Market Share by Country in 2021
Figure 23. Americas Biosimilar Consumption Market Share by Type in 2021
Figure 24. Americas Biosimilar Market Size Market Share by Application in 2021
Figure 25. United States Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 26. Canada Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 27. Mexico Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 28. Brazil Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 29. APAC Biosimilar Market Size Market Share by Region in 2021
Figure 30. APAC Biosimilar Market Size Market Share by Application in 2021
Figure 31. China Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 32. Japan Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 33. Korea Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 34. Southeast Asia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 35. India Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 36. Australia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 37. Europe Biosimilar Market Size Market Share by Country in 2021
Figure 38. Europe Biosimilar Market Size Market Share by Type in 2021
Figure 39. Europe Biosimilar Market Size Market Share by Application in 2021
Figure 40. Germany Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 41. France Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 42. UK Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 43. Italy Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 44. Russia Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 45. Middle East & Africa Biosimilar Market Size Market Share by Region in 2021
Figure 46. Middle East & Africa Biosimilar Market Size Market Share by Type in 2021
Figure 47. Middle East & Africa Biosimilar Market Size Market Share by Application in 2021
Figure 48. Egypt Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 49. South Africa Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 50. Israel Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 51. Turkey Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 52. GCC Country Biosimilar Market Size Growth 2017-2022 ($ Millions)
Figure 53. Americas Biosimilar Market Size 2023-2028 ($ Millions)
Figure 54. APAC Biosimilar Market Size 2023-2028 ($ Millions)
Figure 55. Europe Biosimilar Market Size 2023-2028 ($ Millions)
Figure 56. Middle East & Africa Biosimilar Market Size 2023-2028 ($ Millions)
Figure 57. United States Biosimilar Market Size 2023-2028 ($ Millions)
Figure 58. Canada Biosimilar Market Size 2023-2028 ($ Millions)
Figure 59. Mexico Biosimilar Market Size 2023-2028 ($ Millions)
Figure 60. Brazil Biosimilar Market Size 2023-2028 ($ Millions)
Figure 61. China Biosimilar Market Size 2023-2028 ($ Millions)
Figure 62. Japan Biosimilar Market Size 2023-2028 ($ Millions)
Figure 63. Korea Biosimilar Market Size 2023-2028 ($ Millions)
Figure 64. Southeast Asia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 65. India Biosimilar Market Size 2023-2028 ($ Millions)
Figure 66. Australia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 67. Germany Biosimilar Market Size 2023-2028 ($ Millions)
Figure 68. France Biosimilar Market Size 2023-2028 ($ Millions)
Figure 69. UK Biosimilar Market Size 2023-2028 ($ Millions)
Figure 70. Italy Biosimilar Market Size 2023-2028 ($ Millions)
Figure 71. Russia Biosimilar Market Size 2023-2028 ($ Millions)
Figure 72. Spain Biosimilar Market Size 2023-2028 ($ Millions)
Figure 73. Egypt Biosimilar Market Size 2023-2028 ($ Millions)
Figure 74. South Africa Biosimilar Market Size 2023-2028 ($ Millions)
Figure 75. Israel Biosimilar Market Size 2023-2028 ($ Millions)
Figure 76. Turkey Biosimilar Market Size 2023-2028 ($ Millions)
Figure 77. GCC Countries Biosimilar Market Size 2023-2028 ($ Millions)
Similar Reports
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
- Publish Date: June 24, 2019
- $1050
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
- Publish Date: February 18, 2019
- $1290
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...
- Publish Date: December 11, 2018
- $1390
